Advertisement

E-cigarettes and Atherosclerotic Cardiovascular Disease: What Clinicians and Researchers Need to Know

  • Audrey DarvilleEmail author
  • Ellen J. Hahn
Coronary Heart Disease (S. Virani and S. Naderi, Section Editors)
  • 81 Downloads
Part of the following topical collections:
  1. Topical Collection on Coronary Heart Disease

Abstract

Purpose of Review

Electronic cigarettes, commonly known as electronic nicotine delivery systems (ENDS), e-cigarettes, or vapes, are growing in use and popularity. E-cigarettes are not one distinct type of product. These devices have evolved from the initial “cigarette-alike” designs to larger tank-style devices and most recently, smaller “mod-pods” that can be easily hidden. E-cigarettes can deliver nicotine at levels similar to conventional cigarettes.

Recent Findings

As with conventional cigarettes, e-cigarettes expose users to chemicals and particulates that affect many biological systems including the heart, lungs, and circulation. Most e-cigarettes contain and emit potentially toxic but highly variable substances. Only by using them in total abstinence from combustible tobacco products can users reduce (not eliminate) their exposure to these harmful chemicals. However, most adults smoking e-cigarettes are dual users, meaning they smoke both conventional and e-cigarettes.

Summary

This review of the current cardiovascular-specific literature related to e-cigarette use explores what is known (and unknown) about the short- and long-term effects of using these devices. Specifically, the effects of nicotine, oxidizing agents, and particulates in e-cigarettes are examined in the context of cardiovascular and lung health. The goal is to assist clinicians when discussing e-cigarettes with their patients and to help them analyze the impact of use on cardiovascular health. Recommendations are provided related to clinical treatment and research to address gaps in the literature.

Keywords

E-cigarette ENDS Vaping Nicotine Cardiovascular disease 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Audrey Darville and Ellen J. Hahn declare no conflict of interest. Dr. Darville is the President of the Association for the Treatment of Tobacco Use and Dependence (ATTUD), a non-profit professional organization of providers dedicated to the promotion of and increased access to evidence-based tobacco treatment for the tobacco user.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • King BA, Gammon DG, Marynak KL, Rogers T. Electronic cigarette sales in the united states, 2013-2017. JAMA. 2018;320(13):1379–80.  https://doi.org/10.1001/jama.2018.10488. Recent data on e-cigarette prevalence. CrossRefPubMedGoogle Scholar
  2. 2.
    Burns K. JUUL statement about altria minority investment and service agreements. In: JUUL Newsroom. 2018. https://newsroom.juul.com/2018/12/20/juul-statement-about-altria-minority-investment-and-service-agreements/. Accessed 23 Jan 2019.
  3. 3.
    Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatrics. 2017;171(8):788–97.  https://doi.org/10.1001/jamapediatrics.2017.1488.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Pisinger C, Godtfredsen N, Bender AM. A conflict of interest is strongly associated with tobacco industry-favourable results, indicating no harm of e-cigarettes. Prev Med. 2019;119:124–31.  https://doi.org/10.1016/j.ypmed.2018.12.011.CrossRefPubMedGoogle Scholar
  5. 5.
    Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218–25.  https://doi.org/10.1159/000360220.CrossRefPubMedGoogle Scholar
  6. 6.
    Polosa R. E-cigarettes: Public Health England’s evidence based confusion? Lancet. 2015;386(10000):1237–8.  https://doi.org/10.1016/S0140-6736(15)00133-6.CrossRefPubMedGoogle Scholar
  7. 7.
    U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress: A report of the surgeon general. Atlanta (GA); 2014.Google Scholar
  8. 8.
    Dunbar A, Gotsis W, Frishman W. Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review. Cardiol Rev. 2013;21(2):94–100.  https://doi.org/10.1097/CRD.0b013e31827362e4.CrossRefPubMedGoogle Scholar
  9. 9.
    World Health Organization. WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies; Executive Summary. Report. Geneva: World Health Organization; 2017.Google Scholar
  10. 10.
    • Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016.  https://doi.org/10.1016/j.tcm.2016.03.001. Summary of cardiovascular effects of nicotine related to delivery systems.
  11. 11.
    McEvoy JW, Nasir K, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(4):1002–10.  https://doi.org/10.1161/ATVBAHA.114.304960.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kianoush S, Yakoob MY, Al-Rifai M, DeFilippis AP, Bittencourt MS, Duncan BB, et al. Associations of cigarette smoking with subclinical inflammation and atherosclerosis: ELSA-Brasil (the Brazilian longitudinal study of adult health). J Am Heart Assoc. 2017;6(6).  https://doi.org/10.1161/JAHA.116.005088.
  13. 13.
    Freitas F, Brucker N, Durgante J, Bubols G, Bulcao R, Moro A, et al. Urinary 1-hydroxypyrene is associated with oxidative stress and inflammatory biomarkers in acute myocardial infarction. Int J Environ Res Public Health. 2014;11(9):9024–37.  https://doi.org/10.3390/ijerph110909024.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lubin JH, Couper D, Lutsey PL, Woodward M, Yatsuya H, Huxley RR. Risk of cardiovascular disease from cumulative cigarette use and the impact of smoking intensity. Epidemiology. 2016;27(3):395–404.  https://doi.org/10.1097/EDE.0000000000000437.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Inoue-Choi M, Liao LM, Reyes-Guzman C, Hartge P, Caporaso N, Freedman ND. Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health-AARP Diet and Health Study. JAMA internal medicine. 2017;177(1):87–95.  https://doi.org/10.1001/jamainternmed.2016.7511.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease : a report of the Surgeon General. Rockville: U.S. Public Health Service; 2010.Google Scholar
  17. 17.
    Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(9536):647–58.  https://doi.org/10.1016/S0140-6736(06)69249-0.CrossRefPubMedGoogle Scholar
  18. 18.
    •• National Academy of Sciences E, and Medicine. Public health consequences of e-cigarettes. Washington, D.C.; 2018. Summary and grading of recent evidence of the health effects of e-cigarette use. Google Scholar
  19. 19.
    Cheng T. Chemical evaluation of electronic cigarettes. Tobacco Control. 2014;23(suppl 2):ii11–i7.  https://doi.org/10.1136/tobaccocontrol-2013-051482.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    St Helen G, Dempsey DA, Havel CM, Jacob P 3rd, Benowitz NL. Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes. Drug Alcohol Depend. 2017;178:391–8.  https://doi.org/10.1016/j.drugalcdep.2017.05.042.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Jaber RM, Mirbolouk M, DeFilippis AP, Maziak W, Keith R, Payne T, et al. Electronic cigarette use prevalence, associated factors, and pattern by cigarette smoking status in the United States from NHANES (National Health and Nutrition Examination Survey) 2013-2014. J Am Heart Assoc. 2018;7(14).  https://doi.org/10.1161/JAHA.117.008178.
  22. 22.
    Pope CA 3rd, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, et al. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009;120(11):941–8.  https://doi.org/10.1161/CIRCULATIONAHA.109.857888.CrossRefPubMedGoogle Scholar
  23. 23.
    Fuoco FC, Buonanno G, Stabile L, Vigo P. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ Pollut. 2014;184:523–9.  https://doi.org/10.1016/j.envpol.2013.10.010.CrossRefPubMedGoogle Scholar
  24. 24.
    • Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018.  https://doi.org/10.1016/j.amepre.2018.05.004. Analysis of national data linking e-cigarette use to increased risk of MI.
  25. 25.
    Sandhu RK, Jimenez MC, Chiuve SE, Fitzgerald KC, Kenfield SA, Tedrow UB, et al. Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ Arrhythm Electrophysiol. 2012;5(6):1091–7.  https://doi.org/10.1161/CIRCEP.112.975219.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    DeJarnett N, Conklin DJ, Riggs DW, Myers JA, O'Toole TE, Hamzeh I, et al. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc. 2014;3(4).  https://doi.org/10.1161/JAHA.114.000934.
  27. 27.
    Chaumont M, de Becker B, Zaher W, Culie A, Deprez G, Melot C, et al. Differential effects of e-cigarette on microvascular endothelial function, arterial stiffness and oxidative stress: a randomized crossover trial. Sci Rep. 2018;8(1):10378.  https://doi.org/10.1038/s41598-018-28723-0.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord. 2014;14:78.  https://doi.org/10.1186/1471-2261-14-78.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Ikonomidis I, Vlastos D, Kourea K, Kostelli G, Varoudi M, Pavlidis G, et al. Electronic cigarette smoking increases arterial stiffness and oxidative stress to a lesser extent than a single conventional cigarette: an acute and chronic study. Circulation. 2018;137(3):303–6.  https://doi.org/10.1161/CIRCULATIONAHA.117.029153.CrossRefPubMedGoogle Scholar
  30. 30.
    Moheimani RS, Bhetraratana M, Peters KM, Yang BK, Yin F, Gornbein J, et al. Sympathomimetic effects of acute e-cigarette use: role of nicotine and non-nicotine constituents. J Am Heart Assoc 2017;6(9).  https://doi.org/10.1161/JAHA.117.006579.
  31. 31.
    Nocella C, Biondi-Zoccai G, Sciarretta S, Peruzzi M, Pagano F, Loffredo L, et al. Impact of tobacco versus electronic cigarette smoking on platelet function. Am J Cardiol. 2018;122(9):1477–81.  https://doi.org/10.1016/j.amjcard.2018.07.029.CrossRefPubMedGoogle Scholar
  32. 32.
    • Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018;1(8):e185937.  https://doi.org/10.1001/jamanetworkopen.2018.5937. Comparative analysis of toxicant exposure in electronic versus conventional cigarettes. CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Coleman B, Rostron B, Johnson SE, Persoskie A, Pearson J, Stanton C, et al. Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) study, waves 1 and 2 (2013-2015). Tob Control. 2019;28(1):50–9.  https://doi.org/10.1136/tobaccocontrol-2017-054174.CrossRefPubMedGoogle Scholar
  34. 34.
    Goniewicz ML, Boykan R, Messina CR, Eliscu A, Tolentino J. High exposure to nicotine among adolescents who use Juul and other vape pod systems (‘pods’). Tob Control. 2018.  https://doi.org/10.1136/tobaccocontrol-2018-054565.
  35. 35.
    Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295–303.  https://doi.org/10.1056/NEJMra0809890.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest. 2012;141(4):1110–3.  https://doi.org/10.1378/chest.11-1334.CrossRefPubMedGoogle Scholar
  37. 37.
    • Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L193–206.  https://doi.org/10.1152/ajplung.00071.2017. Review of pulmonary effects associated with e-cigarette use. CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Polosa R. Electronic cigarette use and harm reversal: emerging evidence in the lung. BMC Med. 2015;13:54.  https://doi.org/10.1186/s12916-015-0298-3.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Clapp PW, Jaspers I. Electronic cigarettes: their constituents and potential links to asthma. Curr Allergy Asthma Rep. 2017;17(11):79.  https://doi.org/10.1007/s11882-017-0747-5.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.Google Scholar
  41. 41.
    Lodrup Carlsen KC, Skjerven HO, Carlsen KH. The toxicity of e-cigarettes and children’s respiratory health. Paediatr Respir Rev. 2018.  https://doi.org/10.1016/j.prrv.2018.01.002.
  42. 42.
    Soule EK, Maloney SF, Spindle TR, Rudy AK, Hiler MM, Cobb CO. Electronic cigarette use and indoor air quality in a natural setting. Tob Control. 2017;26(1):109–12.  https://doi.org/10.1136/tobaccocontrol-2015-052772.CrossRefPubMedGoogle Scholar
  43. 43.
    Bourdrel T, Bind MA, Bejot Y, Morel O, Argacha JF. Cardiovascular effects of air pollution. Arch Cardiovasc Dis. 2017;110(11):634–42.  https://doi.org/10.1016/j.acvd.2017.05.003.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Fiordelisi A, Piscitelli P, Trimarco B, Coscioni E, Iaccarino G, Sorriento D. The mechanisms of air pollution and particulate matter in cardiovascular diseases. Heart Fail Rev. 2017;22(3):337–47.  https://doi.org/10.1007/s10741-017-9606-7.CrossRefPubMedGoogle Scholar
  45. 45.
    Ballbe M, Martinez-Sanchez JM, Sureda X, Fu M, Perez-Ortuno R, Pascual JA, et al. Cigarettes vs. e-cigarettes: passive exposure at home measured by means of airborne marker and biomarkers. Environ Res. 2014;135:76–80.  https://doi.org/10.1016/j.envres.2014.09.005.CrossRefPubMedGoogle Scholar
  46. 46.
    Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res. 2014;16(6):655–62.  https://doi.org/10.1093/ntr/ntt203.CrossRefPubMedGoogle Scholar
  47. 47.
    • Fernandez E, Ballbe M, Sureda X, Fu M, Salto E, Martinez-Sanchez JM. Particulate matter from electronic cigarettes and conventional cigarettes: a systematic review and observational study. Curr Environ Health Rep. 2015;2(4):423–9.  https://doi.org/10.1007/s40572-015-0072-x. Review of e-cigarette aerosol particulate exposure. CrossRefPubMedGoogle Scholar
  48. 48.
    Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25(2):91–101.  https://doi.org/10.3109/08958378.2012.758197.CrossRefPubMedGoogle Scholar
  49. 49.
    World Health Organization. Electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS/ENNDS). Conference of the Parties to the WHO Framework Convention on Tobacco Control. 2016.Google Scholar
  50. 50.
    Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013;8(3):e57987.  https://doi.org/10.1371/journal.pone.0057987.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the third National Health and Nutrition Examination Survey. PLOS Medicine. 2005;2(6):e160.  https://doi.org/10.1371/journal.pmed.0020160.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;(5).  https://doi.org/10.1002/14651858.CD000165.pub4.
  53. 53.
    Majeed BA, Weaver SR, Gregory KR, Whitney CF, Slovic P, Pechacek TF, et al. Changing perceptions of harm of e-cigarettes among U.S. adults, 2012-2015. Am J Prev Med. 2017;52(3):331–8.  https://doi.org/10.1016/j.amepre.2016.08.039.CrossRefPubMedGoogle Scholar
  54. 54.
    Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Rockville: U.S. Department of Health and Human Services; 2008.Google Scholar
  55. 55.
    Song F, Maskrey V, Blyth A, Brown TJ, Barton GR, Aveyard P, et al. Differences in longer-term smoking abstinence after treatment by specialist or nonspecialist advisors: secondary analysis of data from a relapse prevention trial. Nicotine Tob Res. 2016;18(5):1061–6.  https://doi.org/10.1093/ntr/ntv148.CrossRefPubMedGoogle Scholar
  56. 56.
    Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, et al. NIH electronic cigarette workshop: developing a research agenda. Nicotine Tob Res. 2015;17(2):259–69.  https://doi.org/10.1093/ntr/ntu214.CrossRefPubMedGoogle Scholar
  57. 57.
    Bhatnagar A. Cardiovascular perspective of the promises and perils of e-cigarettes. Circ Res. 2016;118(12):1872–5.  https://doi.org/10.1161/CIRCRESAHA.116.308723.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    •• Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, et al. Electronic Cigarettes. Policy Statement Am Heart Assoc. 2014;130(16):1418–36.  https://doi.org/10.1161/cir.0000000000000107. AHA policy statement on e-cigarettes. CrossRefGoogle Scholar
  59. 59.
    Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T. Electronic nicotine delivery systems: a research agenda. Tob Control. 2011;20(3):243–8.  https://doi.org/10.1136/tc.2010.042168.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Pierce JP, Sargent JD, Portnoy DB, White M, Noble M, Kealey S, et al. Association between receptivity to tobacco advertising and progression to tobacco use in youth and young adults in the PATH study. JAMA Pediatr. 2018;172(5):444–51.  https://doi.org/10.1001/jamapediatrics.2017.5756.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Tobacco Prevention and Treatment Division, BREATHE, College of NursingUniversity of KentuckyLexingtonUSA
  2. 2.BREATHE, College of NursingUniversity of KentuckyLexingtonUSA

Personalised recommendations